$STSS
Sharps Technology Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223028571 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.130M $2.308M $2.231M
YoY Change 59.02% 3.46% 331.67%
% of Gross Profit
Research & Development $225.2K $224.3K $556.9K
YoY Change -50.79% -59.73% 48.3%
% of Gross Profit
Depreciation & Amortization $210.0K $232.6K $83.05K
YoY Change 65.24% 180.04% 2272.86%
% of Gross Profit
Operating Expenses $2.358M $2.532M $2.788M
YoY Change 31.23% -9.16% 243.78%
Operating Profit -$2.358M -$2.532M -$2.788M
YoY Change 31.23% -9.16% 243.78%
Interest Expense $10.00K $16.62K -$1.101M
YoY Change -48.29% -101.51% -458645.83%
% of Operating Profit
Other Income/Expense, Net $336.0K -$73.49K $3.265M
YoY Change -155.9% -102.25% 1360492.92%
Pretax Income -$2.020M -$2.606M $477.8K
YoY Change -15.77% -645.44% -158.93%
Income Tax
% Of Pretax Income
Net Earnings -$2.022M -$2.606M $477.8K
YoY Change -15.67% -645.43% -158.93%
Net Earnings / Revenue
Basic Earnings Per Share -$0.17 -$0.22 $0.06
Diluted Earnings Per Share -$0.17 -$0.22 $55.11K
COMMON SHARES
Basic Shares Outstanding 11.66M shares 11.66M shares 8.669M shares
Diluted Shares Outstanding 11.81M shares 11.66M shares 8.669M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.550M $2.924M $7.808M
YoY Change -13.14% -62.55% 1528.88%
Cash & Equivalents $5.554M $2.924M $7.808M
Short-Term Investments
Other Short-Term Assets $90.00K $193.9K $35.54K
YoY Change 17.74% 445.53% -28.92%
Inventory $1.287M $992.5K $127.4K
Prepaid Expenses $35.54K
Receivables
Other Receivables
Total Short-Term Assets $6.932M $4.110M $7.971M
YoY Change 3.46% -48.43% 1405.81%
LONG-TERM ASSETS
Property, Plant & Equipment $6.913M $7.093M $4.181M
YoY Change 4.04% 69.64% 23428.98%
Goodwill
YoY Change
Intangibles $52.82K $60.99K
YoY Change -4.71%
Long-Term Investments
YoY Change
Other Assets $526.8K $590.7K $2.874M
YoY Change 179.15% -79.44% 18.31%
Total Long-Term Assets $7.440M $7.684M $7.055M
YoY Change 8.88% 8.91% 188.32%
TOTAL ASSETS
Total Short-Term Assets $6.932M $4.110M $7.971M
Total Long-Term Assets $7.440M $7.684M $7.055M
Total Assets $14.37M $11.79M $15.03M
YoY Change 6.2% -21.51% 404.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $900.0K $825.6K $558.3K
YoY Change 26.36% 47.88% 378.2%
Accrued Expenses $510.0K $574.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.584M $2.913M $3.024M
YoY Change -6.01% -3.68% 2490.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.584M $2.913M $3.024M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.776M $3.105M $3.024M
YoY Change -0.98% 2.67% 2490.25%
SHAREHOLDERS EQUITY
Retained Earnings -$22.05M -$20.03M -$12.06M
YoY Change 52.49% 66.05%
Common Stock $1.528K $1.166K $922.00
YoY Change 65.73% 26.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.60M $8.689M $12.00M
YoY Change
Total Liabilities & Shareholders Equity $14.37M $11.79M $15.03M
YoY Change 6.2% -21.51% 404.87%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$2.022M -$2.606M $477.8K
YoY Change -15.67% -645.43% -158.93%
Depreciation, Depletion And Amortization $210.0K $232.6K $83.05K
YoY Change 65.24% 180.04% 2272.86%
Cash From Operating Activities -$2.010M -$2.068M -$1.877M
YoY Change 54.86% 10.19% 169.59%
INVESTING ACTIVITIES
Capital Expenditures -$110.0K $179.3K -$463.4K
YoY Change -5.43% -138.69% -25.65%
Acquisitions
YoY Change
Other Investing Activities -$200.0K $0.00 -$2.310M
YoY Change 1183.7% -100.0% 22414.62%
Cash From Investing Activities -$90.00K -$179.3K -$2.773M
YoY Change -31.77% -93.54% 337.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.790M 0.000 12.20M
YoY Change -100.0% 3386.57%
NET CHANGE
Cash From Operating Activities -2.010M -2.068M -1.877M
Cash From Investing Activities -90.00K -179.3K -2.773M
Cash From Financing Activities 4.790M 0.000 12.20M
Net Change In Cash 2.690M -2.248M 7.553M
YoY Change -288.14% -129.76% -870.85%
FREE CASH FLOW
Cash From Operating Activities -$2.010M -$2.068M -$1.877M
Capital Expenditures -$110.0K $179.3K -$463.4K
Free Cash Flow -$1.900M -$2.248M -$1.414M
YoY Change 60.8% 58.99% 1836.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001737995
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
STSS Payments To Acquire Other Assets Escrow Deposit
PaymentsToAcquireOtherAssetsEscrowDeposit
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
STSS Proceeds From Subscriptions Receivable
ProceedsFromSubscriptionsReceivable
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
STSS Common Stock Issued And Vested Stock Options For Fixed Assets Acquired
CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired
usd
STSS Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition
CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41355
dei Entity Registrant Name
EntityRegistrantName
Sharps Technology, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3751728
dei Entity Address Address Line1
EntityAddressAddressLine1
105 Maxess Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Melville
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11747
dei City Area Code
CityAreaCode
(631)
dei Local Phone Number
LocalPhoneNumber
574 -4436
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11655936 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2924019 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4170897 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
193875 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
66749 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
992547 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
185804 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
4110441 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4423450 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7092954 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7004890 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
590740 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
411316 usd
CY2023Q2 us-gaap Assets
Assets
11794135 usd
CY2022Q4 us-gaap Assets
Assets
11839656 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
825622 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
543226 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
574057 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
311458 usd
CY2023Q2 STSS Warrant Liability
WarrantLiability
1513187 usd
CY2022Q4 STSS Warrant Liability
WarrantLiability
1151838 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2912866 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2006522 usd
CY2023Q2 STSS Deferred Tax Liability
DeferredTaxLiability
192000 usd
CY2022Q4 STSS Deferred Tax Liability
DeferredTaxLiability
192000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3104866 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2198522 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11655936 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11655936 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9407415 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9407415 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1166 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
941 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28154012 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24733306 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
559112 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
214253 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20025021 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15307366 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8689269 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9641134 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11794135 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11839656 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
224260 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
556868 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
558148 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1063243 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2308075 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2230801 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4291987 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3061710 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2532335 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2787669 usd
us-gaap Operating Expenses
OperatingExpenses
4850135 usd
us-gaap Operating Expenses
OperatingExpenses
4124953 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2532335 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2787669 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4850135 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4124953 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
40079 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1100507 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
76871 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1345944 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-90108 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
4365930 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
93977 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
4078930 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23461 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-38368 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-73490 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3265423 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
132480 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2732986 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2605825 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
477754 usd
us-gaap Net Income Loss
NetIncomeLoss
-4717655 usd
us-gaap Net Income Loss
NetIncomeLoss
-1391967 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11655936 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11655936 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8669372 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8669372 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11193740 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11193740 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6928217 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6928217 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2605825 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
477754 usd
us-gaap Net Income Loss
NetIncomeLoss
-4717655 usd
us-gaap Net Income Loss
NetIncomeLoss
-1391967 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
73786 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
344859 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2532039 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
477754 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4372796 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1391967 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9641134 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9641134 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2111830 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2783385 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
383100 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
270983 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10966772 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10966772 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2605825 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
254446 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
73876 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8689269 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8689269 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3136197 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3136197 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1869721 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
328460 usd
CY2022Q1 STSS Stock Issued During Period Collections Of Common Stock Subscriptions Value
StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
32500 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1627436 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1627436 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
477754 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
477754 usd
CY2022Q2 STSS Stock Issued During Period Value Initial Public Offering
StockIssuedDuringPeriodValueInitialPublicOffering
8974657 usd
CY2022Q2 STSS Stock Issued During Period Value Contingent Stock Liability
StockIssuedDuringPeriodValueContingentStockLiability
496000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
365606 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60551 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
12002004 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
12002004 usd
us-gaap Net Income Loss
NetIncomeLoss
-4717655 usd
us-gaap Net Income Loss
NetIncomeLoss
-1391967 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
448657 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
156100 usd
us-gaap Share Based Compensation
ShareBasedCompensation
637547 usd
us-gaap Share Based Compensation
ShareBasedCompensation
650104 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1299985 usd
STSS Fair Market Value Adjustment For Contingent Warrants
FairMarketValueAdjustmentForContingentWarrants
-181000 usd
STSS Fair Market Value Adjustment For Contingent Warrants And Warrants
FairMarketValueAdjustmentForContingentWarrantsAndWarrants
-93977 usd
STSS Fair Market Value Adjustment For Contingent Warrants And Warrants
FairMarketValueAdjustmentForContingentWarrantsAndWarrants
-3897930 usd
STSS Ipo Issuance Costs Relating To Warrants
IpoIssuanceCostsRelatingToWarrants
550433 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-30141 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
119761 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
27542 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
769088 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5448 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
453136 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-245840 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4131000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3093105 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
342525 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
463355 usd
STSS Payments To Acquire Other Assets Escrow Deposit
PaymentsToAcquireOtherAssetsEscrowDeposit
2350000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-342525 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2813355 usd
STSS Net Proceeds From Initial Public Offering And Additional Offering
NetProceedsFromInitialPublicOfferingAndAdditionalOffering
3238711 usd
STSS Net Proceeds From Initial Public Offering And Additional Offering
NetProceedsFromInitialPublicOfferingAndAdditionalOffering
14202975 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2000000 usd
STSS Proceeds From Subscriptions Receivable
ProceedsFromSubscriptionsReceivable
32500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3238711 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12235475 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-12064 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1246878 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6329015 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4170897 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1479166 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2924019 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7808181 usd
us-gaap Interest Paid Net
InterestPaidNet
47111 usd
STSS Fmv For Common Stock Issued For Contingent Shares
FmvForCommonStockIssuedForContingentShares
496000 usd
STSS Common Stock Issued And Vested Stock Options For Fixed Assets Acquired
CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired
63612 usd
STSS Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition
CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition
40901 usd
CY2023Q2 STSS Working Capital
WorkingCapital
1197575 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9000000.0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zFlBhmw4Miwh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zH5sekUqo6j1">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As of June 30, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5200000 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
235000 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
290551 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19836 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.3745 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0358 pure
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
226062 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106088 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
86831 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
49144 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
679654 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
30572 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
992547 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
185804 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8217930 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7684614 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1124976 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
679724 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7092954 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7004890 usd
us-gaap Depreciation
Depreciation
445252 usd
us-gaap Depreciation
Depreciation
156100 usd
STSS Remaining Payments Due On Machinery
RemainingPaymentsDueOnMachinery
100000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
60993 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62480 usd
CY2023Q2 us-gaap Deposits Assets
DepositsAssets
517377 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
336466 usd
CY2023Q2 STSS Other Non Current
OtherNonCurrent
12370 usd
CY2022Q4 STSS Other Non Current
OtherNonCurrent
12370 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
590740 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
411316 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
7928 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1487 usd
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2800000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
455326 usd
CY2023Q2 STSS Warrant Liability
WarrantLiability
1513187 usd
CY2023Q2 STSS Warrant Liability
WarrantLiability
1513187 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11431316 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11431316 shares
CY2023Q2 STSS Fair Market Value Of Note Warrants
FairMarketValueOfNoteWarrants
30588 usd
CY2023Q2 STSS Fair Market Value Of Trading And Overall Warrants
FairMarketValueOfTradingAndOverallWarrants
1121250 usd
CY2023Q2 STSS Fair Market Value Of Trading And Overall Warrants Issuance
FairMarketValueOfTradingAndOverallWarrantsIssuance
455326 usd
CY2023Q2 STSS Fair Market Value Of Change In Fair Value Of Warrant Liability
FairMarketValueOfChangeInFairValueOfWarrantLiability
93977 usd
CY2023Q2 STSS Warrant Liability
WarrantLiability
1513187 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1358122 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.37
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1025000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
25714 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.75
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2357408 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.08
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1665378 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.63
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
725355 usd
CY2022Q1 STSS Stock Based Charges Relating To Purchase Of Machinery
StockBasedChargesRelatingToPurchaseOfMachinery
63512 usd
CY2022Q1 STSS Stock Based Charges Relating To Acquisition
StockBasedChargesRelatingToAcquisition
40901 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0 pure
us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0 pure
us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0 pure
CY2023Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2924019 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2924019 usd
CY2023Q2 STSS Warrant Liability
WarrantLiability
1513187 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1513187 usd
STSS Order Costs To Purchase Equipment And Molds
OrderCostsToPurchaseEquipmentAndMolds
490651 usd
STSS Progress Payments
ProgressPayments
280349 usd
us-gaap Severance Costs1
SeveranceCosts1
346000 usd
CY2023Q2 STSS Medical Benefits Cost
MedicalBenefitsCost
29000 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
235000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
50000 shares
CY2023Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.30

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001493152-23-028571-index-headers.html Edgar Link pending
0001493152-23-028571-index.html Edgar Link pending
0001493152-23-028571.txt Edgar Link pending
0001493152-23-028571-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stss-20230630.xsd Edgar Link pending
stss-20230630_cal.xml Edgar Link unprocessable
stss-20230630_def.xml Edgar Link unprocessable
stss-20230630_lab.xml Edgar Link unprocessable
stss-20230630_pre.xml Edgar Link unprocessable